CION Ameerpet
Radiation Therapy · Theranostics & Radioisotope Therapy
Protecting Your Kidneys and Bone Marrow — During Radioisotope Therapy
Medically reviewed by Dr. Gangadhar Vajrala, Radiation Oncologist (MBBS · MD, Radiation Oncology · MPH) · Last reviewed August 2026
Your kidneys clear the part of the dose the cancer does not take up, and your bone marrow sits right beside the bone being treated. Those two organs decide how a radioisotope course runs. This page explains why they are at risk, exactly what protection is given at each cycle, and what is measured before the next dose is approved — including what changes if your kidney function is already reduced.
- Why the kidneys, specifically — the clearance route explained in one paragraph, so you know what the risk actually is instead of guessing.
- The protection you should be getting — hydration, a protective amino-acid infusion and relief of any urinary blockage — named step by step so you can check.
- Every test, and what a change triggers — the monitoring table to take to your appointment, including what continues after the final cycle.
- Already have kidney disease? — the framework your team uses to decide eligibility, so a borderline result is discussed rather than assumed.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The short answer
Why are the kidneys at risk during radioisotope therapy?
Radioisotope therapy circulates in your blood, and whatever the cancer does not take up leaves through the kidneys. On the way out, part of it is briefly held in the kidney’s filtering tubules. That short holding time delivers a small radiation dose to healthy kidney tissue, which is why protection is planned in advance.
If you have been told your kidneys are “a concern” for this treatment, that sentence usually lands as a door closing. It is more often the opposite. Kidney protection is one of the most worked-out parts of a radioisotope protocol — there is a defined set of steps, they happen at every cycle, and they exist precisely because the risk was recognised long before you walked in.
Two organs carry the load. The kidneys clear the dose the cancer does not bind. The bone marrow sits immediately alongside bone, so marrow near treated bone deposits receives radiation as well. Almost every decision about your dose, your interval between cycles and whether a cycle goes ahead traces back to one of these two. Nothing else on the safety checklist comes close in importance.
This page sets out, in order: why the kidneys are exposed at all, exactly what protection is given, how the marrow is looked after, and what gets measured and when. It is written for people who already have something else going on — reduced kidney function, one working kidney, diabetes, long-standing high blood pressure — because that is the group most often left guessing whether they are eligible. If you are still deciding between treatment types, our comparison of radioisotope therapy and external beam radiation explains when each is used.
Radioisotope therapy is delivered at an NABH-accredited partner nuclear medicine centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout. CION does not own or operate a nuclear medicine facility, a linear accelerator or any other radiotherapy equipment, and is not itself NABH-accredited.
Did you know?
The kidney does not simply filter waste and discard it. Its tubules actively reabsorb small protein-like molecules — including the carrier that delivers the isotope. That is why a protective amino-acid infusion is run alongside the dose at most centres: it competes for the very same reabsorption pathway, so less of the isotope is held in the kidney. It is standard practice in international nuclear medicine guidance, not an optional extra you have to ask for.
The eligibility conversation
Whose kidneys are most at risk, and what changes for them?
None of the situations below is automatically a bar to treatment. Each one changes how carefully you are assessed and how closely you are watched — which is a different thing, and worth knowing before your appointment.
Reduced kidney function, a single working kidney, diabetes, long-standing high blood pressure and a blocked urinary tract all raise the level of care needed. So does dehydration around a cycle. Each is assessed with a measured test rather than an assumption, and several can be corrected before treatment begins.
| Your situation | Why it matters here | What your team does differently |
|---|---|---|
| Kidney function already reduced | Less reserve to absorb the small dose each cycle delivers to kidney tissue | A measured test rather than a single blood value, sometimes a scan that reports each kidney separately, and a decision taken jointly by the radiation oncology and nuclear medicine teams |
| One working kidney | There is no second kidney to compensate if function drifts across a course | Closer monitoring between cycles, careful attention to hydration, and an explicit discussion of what would stop the course |
| Diabetes or long-standing high blood pressure | Both quietly reduce kidney reserve over years, often before any symptom appears | Blood pressure and sugar control reviewed as part of treatment planning, not treated as someone else’s problem |
| A blocked ureter or swollen kidney | A kidney that cannot drain cannot clear the isotope, so it stays in contact longer | The blockage is relieved first, usually with a stent or a drainage tube, before a dose is given |
| Previous treatments known to affect the kidneys | Earlier exposure may have reduced reserve without you noticing | A full treatment history is taken and baseline kidney tests are compared against your older reports |
| Vomiting, diarrhoea or poor fluid intake around a cycle | Dehydration slows clearance, so the isotope lingers in the kidney | You are asked to report these before the cycle so fluids can be given, or the cycle rescheduled |
| Older age, low muscle mass or frailty | A routine blood value can look reassuring while true function is lower | An estimated or measured filtration rate is used instead of the raw number alone |
Guideline bodies including NCCN and ASTRO, together with international nuclear medicine guidance, treat kidney function and marrow reserve as the standard limits for offering and continuing a radioisotope course. Thresholds differ between centres and between isotopes, so ask the treating centre for the numbers they use in your case rather than assuming a figure you read online applies.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get the eligibility question answered before you travel
A radioisotope course runs over months and is planned at a partner centre. One review of your kidney tests, blood counts and scans is free, confidential and carries no obligation to change anything.
Question two
What protection is actually given to the kidneys?
Fluids, an amino-acid infusion and timing. Intravenous fluids start before the dose and continue after it. A protective amino-acid infusion runs alongside the dose so less isotope is reabsorbed by the kidney. Any urinary blockage is relieved first. Then kidney tests decide whether the next cycle goes ahead.
Here is the sequence as it actually runs at a partner nuclear medicine centre, so you can recognise each step when it happens and ask about the one you were not told about.
1
Before the course: the baseline that decides eligibility
A kidney function blood test and an estimated filtration rate are done, and in some cases a nuclear scan that reports each kidney separately. Scans are also reviewed for a blocked or swollen kidney. Ask for a copy of this baseline — every later result is read against it, and it is the single most useful page to carry to a second opinion.
2
Before the dose on the day: hydration
Intravenous fluids are started before the isotope is given and continued afterwards. This is not a formality. Well-hydrated kidneys move the unbound isotope out faster, which shortens the time it spends in contact with kidney tissue. You will be asked to pass urine often through the day for the same reason.
3
Alongside the dose: the protective amino-acid infusion
At most centres a protective amino-acid infusion runs with the treatment. It saturates the reabsorption pathway in the kidney tubules, so a smaller share of the isotope is taken back into kidney tissue on its way out. It can cause nausea during the infusion, which is expected and manageable — tell the nursing team rather than waiting it out.
4
The first days at home: fluids and frequent emptying
Drink steadily unless your fluids have been restricted for a heart or kidney reason, and empty your bladder as soon as you need to rather than holding on. Report vomiting, diarrhoea or fever early, because dehydration undoes step two. Written radiation-safety instructions for the home are given separately by the centre and both sets matter.
5
Between cycles: the go or no-go check
Kidney function is repeated before every cycle. If it has drifted, the response is to widen the interval, adjust the plan or pause — not to push the cycle through and hope. A postponed cycle is a normal part of a course. Our page on how many cycles of radioisotope therapy you will need explains why the total is reviewed as you go.
The second organ
How is the bone marrow protected?
Mostly by measuring and spacing. Blood counts are taken before the course and before every cycle. A cycle is postponed or the interval widened if counts have not recovered. Treatments that also suppress the marrow are not stacked on top. Supportive care is used when your team judges it appropriate.
There is no infusion that shields marrow the way fluids and amino acids help the kidney. Protection here is a schedule, and the schedule only works if the blood tests are actually done on time.
Before the course starts
- A full blood count establishes your starting haemoglobin, white cells and platelets.
- Previous chemotherapy, previous radiation to large areas of bone and widespread disease in bone all reduce reserve, and all are recorded before a dose is planned.
- Where marrow reserve looks borderline, the interval between cycles may be set wider from the start rather than adjusted later.
During the course
- Counts are repeated before every cycle, and the lowest point usually arrives a few weeks after a dose rather than the day after — which is why the test is timed to the schedule, not to how you feel.
- A cycle is postponed if counts have not recovered. This is routine practice, not a sign the treatment has failed.
- Other marrow-suppressing treatment is generally not run alongside a radioisotope course.
- Transfusion or growth-factor support is available if your treating team judges it appropriate for you.
- Fever, chills, bleeding gums, nosebleeds or unusual bruising are reported the same day, not saved for the next appointment.
- Counts continue to be followed for a period after the final cycle, because marrow recovery carries on after treatment ends.
For the wider picture of what to expect between cycles, see our page on the side effects of Lu-177 and radioisotope therapy, which sets out what is common, when it appears and what helps.
Question three
What is monitored, when, and what does a change trigger?
Bring this table to your next appointment. If a test on it has not been done for you, that is a fair and useful question to ask.
Kidney function tests and a full blood count are the two results that decide whether the next cycle goes ahead. Post-dose imaging shows where the isotope went. Depending on the isotope, liver, thyroid and calcium tests are added. Monitoring continues for a period after the final cycle.
| What is checked | When | What it tells your team | What a change triggers |
|---|---|---|---|
| Kidney function blood test | Before the course, then before every cycle | Whether kidney function is holding steady across the course | A wider interval, an adjusted plan or a pause — never pushing the cycle through unchanged |
| Estimated or measured filtration rate | At baseline, and repeated if the blood test drifts | True filtering capacity, which a single blood value can overstate | A referral to a kidney specialist, or a scan reporting each kidney separately |
| Full blood count | Before the course, then before every cycle | Whether marrow has recovered enough for the next dose | The cycle is postponed, or supportive care is added |
| Hydration and urine output review | On dose day and in the days after | Whether the isotope is clearing at the expected rate | Extra intravenous fluids, or admission if you cannot keep fluids down |
| Post-dose scan | Usually after each dose | Where the isotope actually settled in your body | A review of the plan for the remaining cycles |
| Liver, thyroid or calcium tests | Depending on which isotope you are having | Isotope-specific effects outside the kidney and marrow | Referral or a change in supportive care |
| Blood pressure and blood sugar control | Throughout, if you are hypertensive or diabetic | Whether a second, slower source of kidney strain is being managed | Physician review alongside the oncology plan |
| Kidney tests and blood counts after the last cycle | For a period after the course ends | Whether readings recover, hold or drift once treatment stops | Continued follow-up, or a kidney specialist referral |
On cost: the protective infusion, the day-of hydration and the monitoring blood tests are often billed separately from the dose itself. Ask for them to be named line by line in your written estimate before you commit. Any figure a centre quotes is indicative, as of August 2026, and varies between centres.
If you have been told no, or maybe
Can I still be treated if my kidneys are already not normal?
Often yes, with conditions. Reduced kidney function makes the assessment more careful and can change the interval, the plan or the monitoring. It is rarely a single yes or no. What decides it is measured function, whether both kidneys drain freely, how much disease there is, and what other options remain.
This is the question the page exists for, so here is the framework your team works through rather than a recommendation, which only your own doctors can give.
- What is the measured function, not the assumed one? A raw blood value can look worse in a frail patient and better in someone with low muscle mass. A filtration rate, and sometimes a scan reporting each kidney separately, is the honest number.
- Is anything reversible first? A blocked ureter, dehydration or uncontrolled blood pressure can each be addressed before treatment, and doing so sometimes moves a borderline case.
- Is the risk to the kidney weighed against the alternative? The comparison is never against perfect health. It is against what happens with the other options available to you, and how much benefit each is expected to offer.
- Can the plan be modified rather than refused? Wider intervals, fewer cycles reviewed as you go, or closer monitoring are all available before a flat refusal.
- Who is jointly making this call? A radiation oncologist and a nuclear medicine physician should both be part of it, with a kidney specialist involved where function is already reduced.
If the answer you were given came without this reasoning, it is entirely reasonable to ask for it in writing and take it for a second opinion. Availability also varies by city, and a centre with more experience of comorbid patients may assess you differently — our guide to where radioisotope therapy is available in Hyderabad and South India sets out the practical options.
This page does not promise that treatment will be offered to you, or how well it would work. It explains how the decision is made so you can take part in it. Your radiotherapy or radioisotope treatment is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout.
Protection is planned, not improvised
A borderline kidney result deserves a conversation, not a closed door
Reduced kidney function changes how a course is planned and monitored. It is rarely the end of the discussion. Have your reports reviewed and hear the reasoning in full.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Kidney and bone marrow protection — your questions answered
Why are the kidneys at risk during Lu-177 and other radioisotope therapy?
Radioisotope therapy circulates in the blood, and the part of the dose the cancer does not take up leaves the body in urine. On the way out, some of it is briefly reabsorbed and held in the filtering tubules of the kidney, so healthy kidney tissue receives a small radiation dose with every cycle. This is a known and expected feature of the treatment, not a complication, which is why kidney protection is written into the protocol rather than added if a problem appears. It is also why kidney function is measured before you are accepted for treatment and again before every cycle.
What protection is given to the kidneys during radioisotope therapy?
Three things happen together. You are given intravenous fluids starting before the dose and continuing after it, so the isotope is flushed through faster. A protective amino-acid infusion is run alongside the dose at most centres, because it competes for the same reabsorption pathway in the kidney tubules and lowers the dose the kidney holds on to. You are then asked to drink well and pass urine often for the next few days at home. On top of that, any blockage in the urinary tract is looked for and relieved before treatment starts, because a kidney that cannot drain cannot clear the isotope.
How is the bone marrow protected during radioisotope therapy?
Mainly by measurement and spacing. A full blood count is taken before the course and again before every cycle, and a cycle is postponed or the interval widened if haemoglobin, white cells or platelets have not recovered. Treatments that also suppress the marrow are not usually stacked on top of a radioisotope course. Where disease is widespread in bone, or where you have already had chemotherapy, the monitoring is closer because there is less marrow reserve to begin with. Supportive care such as transfusion or growth-factor support is used when your treating team judges it appropriate.
What is monitored during and after radioisotope therapy?
Kidney function blood tests and a full blood count are the two results that decide whether the next cycle goes ahead. Depending on the isotope, liver tests, thyroid tests and calcium may be added. Blood pressure and blood sugar control matter if you are diabetic or hypertensive, because both affect the kidney over time. A scan is usually taken after each dose to show where the isotope actually went. Monitoring does not stop at the last cycle: kidney readings and blood counts are followed for a period afterwards, because changes can appear slowly.
Can I have radioisotope therapy if I already have kidney disease or only one kidney?
Sometimes yes, and this is a conversation rather than a fixed rule. Reduced kidney function, a single working kidney, diabetes and long-standing high blood pressure all make the assessment more careful, but none of them is automatically a bar. Your team looks at your measured kidney function, whether both kidneys drain freely, how much disease there is and what other options remain. A separate test that measures each kidney individually is sometimes added, because an average number can hide one poorly working kidney. Ask for the reasoning in writing so you can take it to a second opinion.
What can I do at home to protect my kidneys between cycles?
Drink steadily through the day unless your team has restricted your fluids for a heart or kidney reason, and do not wait until you feel thirsty. Pass urine as soon as you need to rather than holding on, particularly in the first days after a dose. Report vomiting, diarrhoea or a fever early, because dehydration changes how the isotope clears. Tell every doctor you see that you are on a radioisotope course before any new medicine, scan dye or painkiller is started. Keep every blood report in one folder and take it to each visit.
This page is a general explainer about how the kidneys and bone marrow are protected during radioisotope therapy. It is not medical advice and not a recommendation for your case. Only your treating oncology and nuclear medicine team, working from your own scans and blood tests, can say what applies to you.